Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524779 · ClinicalTrials.gov registry record · NA
BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05524779 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 21 participants.
The verdict
NCT05524779, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive treatment of facial wrinkles.
Interventions
- DEVICE BTL-785-7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2024-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05524779
The ClinicalTrials.gov registry entry for NCT05524779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-785-7 is the first listed.
NCT05524779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05524779 about?
NCT05524779 is a clinical study titled "BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement". This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive treatment of facial wrinkles.
What is the current status of trial NCT05524779?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-10-19. Estimated completion is 2024-06-25.
What interventions are being tested in trial NCT05524779?
The interventions under investigation include: BTL-785-7 (DEVICE).
Who is sponsoring clinical trial NCT05524779?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.